| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Estrogens, Conjugated (USP) | FAERS: 2 | US FAERS | |
| 2 | Adzenys XR-ODT | FAERS: 1 | US FAERS | |
| 3 | Baclofen | FAERS: 1 | US FAERS | |
| 4 | Clozapine | FAERS: 1 | US FAERS | |
| 5 | Dasatinib | FAERS: 1 | US FAERS | |
| 6 | Fondaparinux | FAERS: 1 | US FAERS | |
| 7 | Liraglutide | FAERS: 1 | US FAERS | |
| 8 | Memantine | FAERS: 1 | US FAERS | |
| 9 | Mometasone Furoate | FAERS: 1 | US FAERS | |
| 10 | Zoledronic Acid | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 12 | tofacitinib | FAERS: 1 | US FAERS | |
| 13 | Fenofibrate | OFFSIDES | ||
| 14 | Risedronic Acid | OFFSIDES | ||
| 15 | Triamterene | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.